Nanovega specializes in cancer diagnosis: BioTags™ target cell surface receptors and intracellular domains with exceptional specificity and sensitivity. OncoTags™ target cancer cells specifically, tag them permanently and omit healthy cells entirely. These technologies empower researchers and clinicians with the unsurpassed ability to diagnose cancer cells at early stages, which are otherwise not detectable by any other technology in the world.